Evidences and perspectives of transjugular intrahepatic portosystemic shunt: A bibliometric analysis from 1990 to 2024.

BACKGROUND

Transjugular intrahepatic portosystemic shunt (TIPS) is the mainstay of cirrhotic portal hypertension therapy. The extension of TIPS indications is relatively prevalent in clinical practice these years, but its prognosis is still controversial. However, no bibliometric study in this area has been performed to date.This study aimed to provide insights and perspectives on the development, hotspots and frontiers of TIPS.

METHODS

A total of 3152 related articles from 1990 to 2024 were retrieved from the Web of Science Core Collection database, and assessed using VOSviewer (version 1.6.19), CiteSpace (version 6.3.R1) and Bibliometrix R-package (version 4.3.0).

RESULTS

The United States was the leading country contributing to this field, and the University of Barcelona stood out as the most prominent institution. Journal of Vascular and Interventional Radiology ranked first in publication, while Hepatology received the highest citation frequency. Trebicka Jonel's publication numbers and citations were both on the top ten author list, and demonstrated great total link strength. During this period, "hepatic encephalopathy" was regarded as a persistent hotspot, while "sarcopenia" emerged as the new frontier in the research area.

CONCLUSION

We hypothesize that indication extension, optimal patient selection and the time of intervention will become the main concerns in the near future.